Modafinil: Difference between revisions
>Oskykins |
>Oskykins |
||
Line 60: | Line 60: | ||
==Pharmacology== | ==Pharmacology== | ||
Research suggests that Modafinil increases hypothalamic histamine levels in the brains of rats, which may contribute to its locomotor effects. <ref>European Journal of Pharmacology - Involvement of central histaminergic systems in modafinil-induced but not methylphenidate-induced increases in locomotor activity in rats | http://www.sciencedirect.com/science/article/pii/S001429990701031X</ref> Modafinil also | |||
The reported nondopaminergic effects of modafinil include activation of α1 adrenergic receptors (Duteil et al., 1990), enhancement of serotonin (5-HT) function (Ferraro et al., 2000), inhibition of GABA release (Ferraro et al., 1997, 1998), and stimulation of glutamate and histamine release (Ferraro et al., 1999; Ishizuka et al., 2003). | |||
<ref>The Journal of Pharmacology and Experimental Therapeutics - Evidence for the Involvement of Dopamine Transporters in Behavioral Stimulant Effects of Modafinil | http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2672878</ref> | |||
Modafinil seems to inhibit the reuptake action of the dopamine transporter, thus leading to an increase in extracellular and thus synaptic concentrations of dopamine.[103] | |||
Modafinil seems to inhibit the reuptake action of the dopamine transporter, thus leading to an increase in extracellular and thus synaptic concentrations of dopamine | |||
==Subjective effects== | ==Subjective effects== |